doi: 10.1186/s12891-022-05396-5 Summary Keywords type 2 diabetes, osteoporosis, GLP-1 receptor agonists, electronic medical records, cohort study, bone metabolism, fracture risk Citation Chen M, Lyu Y, Zhao J, Han X, Huang T, Yang T and Zhou Y (2025) Use of GLP-1 receptor agonist and risk of osteoporosis among patients with type 2 diabetes: a real-world study
Dr Wong Siu Kwan, a general practitioner and founder of Amber Family Clinic, said that in her experience, some people with BMI within the normal range tend to view GLP-1 drugs as suitable for cosmetic use or as over-the-counter weight-loss medicines
This implied that LA supplementation may increase xCT expression by inhibiting p53 activation
CPEU/CEU: 1 NOTE: Course Expiration Date: 10/7/2028
Be sure to talk to your doctor for sound advice before starting any weight loss program and understand it will take time and discipline for permanent results